BioSpace News Archive

Press Releases

Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease

March 31, 2026
·
8 min read
Press Releases

BioVersys Strengthens Ansamycin Platform and NTM Research Through Collaboration and License Agreement with Hackensack Meridian Health

March 31, 2026
·
10 min read
Press Releases

Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases

March 31, 2026
·
15 min read
Press Releases

ONWARD Medical Reports Full Year 2025 Financial and Operating Results, Highlighting Strong US Commercial Performance and Major Pipeline Milestones

March 31, 2026
·
15 min read
Press Releases

MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough RWE Results in High-Dose, High-Intensity Neurorehabilitation

March 31, 2026
·
5 min read
Press Releases

MaaT Pharma Announces 2025 Annual Results and Provides Business Updates

March 31, 2026
·
17 min read
Press Releases

Abbisko Therapeutics’ FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children

March 31, 2026
·
2 min read
Press Releases

Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth

March 31, 2026
·
5 min read
Press Releases

AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

March 31, 2026
·
5 min read
Press Releases

Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

March 31, 2026
·
5 min read